Papers

5

Total Citations

103

H-Index

5

About

Wen-Jie Wu is a pioneering surgeon-researcher whose work centers on advancing minimally invasive oncologic surgery, particularly for esophageal cancer and thymic epithelial tumors. Dr. Wu’s major contributions lie in rigorously comparing robotic-assisted techniques against traditional thoraco-laparoscopic approaches. Through propensity score-matched studies and meta-analyses, they have demonstrated that robotic-assisted McKeown esophagectomy (RAME) can achieve superior lymph node dissection and comparable long-term outcomes to conventional minimally invasive esophagectomy (MIE), with key papers accumulating over 60 citations. Their research on thymectomy similarly shows that robotic-assisted thymectomy (RATT) offers advantages in progression-free survival and short-term outcomes over video-assisted thymectomy (VATT), with findings cited more than 35 times. Most recently, Dr. Wu has extended this comparative methodology to lateral lymph node dissection for rectal cancer, evaluating robotic versus laparoscopic surgery. By systematically quantifying the benefits of robotic precision—especially in lymphadenectomy—Dr. Wu provides evidence-based guidance for surgical decision-making, directly impacting clinical practice and patient outcomes in thoracic and gastrointestinal oncology.

Research Focus

Key Achievements

5
H-Index
5
Papers
103
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Long-term outcomes of robotic-assisted versus thoraco-laparoscopic McKeown esophagectomy for esophageal cancer: a propensity score-matched study
31 citations · 2020
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Southeast University, First Affiliated Hospital of University of South China

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago